Back to School: How biopharma can reboot drug development. Access exclusive analysis here

tgAAC94 AAV2/TNFR:Fc: Phase II start

In 2H08, TGEN plans to begin a Phase II

Read the full 91 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE